Duke Royalty is the leading provider of royalty finance to companies in the UK and Europe.
We are long term partners to businesses: our capital enables business owners to grow their businesses without compromising control or ownership and removes refinancing risk.
Our approach enables us to provide robust, predictable and long-term returns to our shareholders.
We invest across a diverse range of sectors, including:
“We are a serious investor in Ireland; we see it as a very attractive opportunity and place for us to do business. We’ve now got a very strong network of both portfolio companies and relationships in the corporate finance community.”
Duke Royalty announced a follow-on investment of around £7.7m into its existing royalty partner, Bakhchysarai Ireland (BIL), on Thursday. It said the new capital would support BIL’s second acquisition, PharmEng, trading as PE Global, which it described as “one of the leading” healthcare and life sciences recruiters in Ireland, with a growing presence in the UK.
Alternative capital provider Duke Royalty announced a follow-on investment of around £7.7m into its existing royalty partner, Bakhchysarai Ireland (BIL), on Thursday.
